(Bloomberg/Mark Gurman) — Apple Inc. is restoring the blood oxygen tracking feature on its smartwatch in the US following a years-long legal fight.

The feature — which was removed at the end of 2023 due to a patent infringement lawsuit filed by Masimo Corp. and a US Customs injunction — will return for Apple Watch owners who bought models with the feature disabled, the company said Thursday, citing a ruling by US Customs.

The restoration comes as part of iOS 18.6.1 and watchOS 11.6.1 software updates — and includes a workaround that shows the data on an iPhone rather than the Apple Watch blood oxygen app itself.

Related Articles

“Following this update, sensor data from the Blood Oxygen app on Apple Watch will be measured and calculated on the paired iPhone, and results can be viewed in

See Full Page